Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional Results available

Open-Label Study of SPN-812 Administered With Psychostimulants in Children and Adolescents With ADHD

ClinicalTrials.gov ID: NCT04786990

Public ClinicalTrials.gov record NCT04786990. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 1, 2026, 9:45 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase IV, Open-Label, Flexible-Dose Safety Trial Evaluating SPN-812 Administered With Psychostimulants in Children and Adolescents (6 to 17 Years of Age) With Attention-Deficit/Hyperactivity Disorder (ADHD)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This open label, flexible-dose study evaluating the safety and efficacy of SPN-812 administered with psychostimulants in children and adolescents (6 to 17 years of age) with Attention-Deficit/Hyperactivity Disorder (ADHD).

Study identification

NCT ID
NCT04786990
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Supernus Pharmaceuticals, Inc.
Industry
Enrollment
96 participants

Conditions and interventions

Eligibility (public fields only)

Age range
6 Years to 17 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 26, 2021
Primary completion
May 22, 2023
Completion
Jul 25, 2023
Last update posted
Apr 30, 2024

2021 – 2023

United States locations

U.S. sites
16
U.S. states
13
U.S. cities
16
Facility City State ZIP Site status
Preferred Research Partners, Inc. Little Rock Arkansas 72211
NRC Research Institute Orange California 92868
Miami Clinical Research Miami Florida 33155
APG Research, LLC Orlando Florida 32803
Elite Clinical Trials Blackfoot Idaho 83221
Elite Clinical Trials Rexburg Idaho 83440
Qualmedica Research, LLC Evansville Indiana 47715
Psychiatric Associates Purehealth Medical Center Overland Park Kansas 66221
Midwest Research Group Saint Charles Missouri 63304
Alivation Research, LLC Lincoln Nebraska 68526
Center for Psychiatry and Behavioral Medicine Las Vegas Nevada 89128
SP Research, PLLC Oklahoma City Oklahoma 73112
Coastal Carolina Research Center North Charleston South Carolina 29405
Gadolin Research, LLC Beaumont Texas 77702
Family Psychiatry of The Woodlands The Woodlands Texas 77381
Northwest Clinical Research Center Bellevue Washington 98007

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

Recently updated Attention-Deficit/Hyperactivity Disorder (ADHD) trials

Other public records listing Attention-Deficit/Hyperactivity Disorder (ADHD). Sorted by last update posted; newest first. Not a recommendation.

All Attention-Deficit/Hyperactivity Disorder (ADHD) trials →

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04786990, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 30, 2024 · Synced Sep 1, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04786990 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →